A main issue for further clinical progress of cancer gene therapy is to develop technologies for efficient and specific delivery of therapeutic genes to tumor cells. In this work, we describe a photochemical treatment that substantially improves gene delivery by adenovirus, one of the most efficient gene delivery vectors known. Transduction of two different cell lines was studied by microscopy, flow cytometry, and an enzymatic assay, employing a -galactosidase -encoding adenovirus. The photochemical treatment induced a >20 -fold increase in gene transduction, compared with conventional adenovirus infection, both when measured as the percentage of cells transduced, and when measured as the total -galactosidase activity in the cell population. The effect was most pronounced at lower virus doses, where in some cases the same transduction efficiency could be achieved with a 20 times lower virus dose than with conventional infection. Photochemical treatments are already in clinical use for cancer therapy, and generally are very specific and have few side effects. The photochemical internalization technology described thus has a clear potential for improving both the efficiency and the specificity of gene delivery in cancer gene therapy, making it possible to achieve efficient site -specific in vivo gene delivery by adenoviral vectors.
O ne of the most important challenges in the clinical development of cancer gene therapy is to find methods for delivering therapeutic genes to the target cells in an efficient and specific way in vivo.
1,2 Most gene therapy vectors, both viral and nonviral, are taken up into the cell by endocytosis, and an important step (and a possible barrier ) in the gene delivery process is the escape of the therapeutic gene from endocytic vesicles so that it can be further translocated to the cell nucleus. Recently we have described a novel technology, named photochemical internalization ( PCI ), for light -induced delivery of a variety of macromolecules into the cell cytosol. 3 -6 In this technology, we employ photosensitizing compounds that localize in endosomes and lysosomes. 7 Upon exposure to light, photochemical effects will cause rupture of the membranes of these endocytic vesicles, so that the constituents of the vesicles can be released into the cytosol. As described in our earlier work PCI constitutes an efficient and light -inducible method for in vitro transfection with plasmid /polylysine complexes. 3, 4, 8, 9 Unfortunately, plasmid / polylysine complexes are very poor agents for in vivo gene delivery. 10 In contrast, adenoviruses are known to be efficient vectors for in vivo gene delivery. 2 The process of adenovirus uptake into the cell and trafficking to the cell nucleus is not fully understood, but it is known that adenovirus binds to receptors on the cell surface, is taken up by endocytosis, escapes from endosomes, and is transported to the nucleus via microtubuli. 11, 12 Although the escape of adenovirus from endosomes is generally believed to be an efficient process, 13, 14 intracellular barriers for gene delivery have been described for other virus vectors, 15 indicating that PCI could have beneficial effects also on virus -mediated gene delivery. In the present work we have investigated the effect of PCI on adenovirus gene transduction of different cell lines, and have shown that the photochemical treatment can substantially improve adenovirus -mediated gene delivery. Thus a more than 20 times increase in transduction efficiency can be observed, meaning that at least in some cases the same transduction efficiency can be achieved with a 20 times lower virus dose than with conventional infection.
Materials and methods

Cells and adenovirus
HCT 116 and WiDr human colon carcinoma cells were obtained from American Type Culture Collection ( ATCC nos. CCL -247 and CCL -218, respectively ). Cells were cultured in RPMI 1640 medium containing 10% fetal calf serum, 100 U /mL penicillin, 100 g /mL streptomycin and 2 mM glutamine ( all from Gibco BRL, Paisley, UK ) at 378C in 5% CO 2 atmosphere.
The recombinant adenovirus AdHCMV-lacZ encoding the E. coli lacZ gene controlled by the human cytomegalovirus promoter was a kind gift from Dr Frank L Graham ( McMaster University, Hamilton, ON, Canada ). The virus was plaque purified, grown to high titer in 293 cells and purified by CsCl banding. 16 The virus solution was diluted in PBS ( 0.15 M NaCl, 0.015 M NaH 2 PO 4 , pH 7.4 ) containing 0.68 mM CaCl 2 and 0.5 mM MgCl 2 to the ( multiplicities of infection ) MOIs employed in the different experiments.
Photochemical treatment
A total of 50,000 cells per well were seeded in six -well plates (Costar ) and incubated overnight at 378C. One milliliter medium containing 20 g/mL AlPcS 2a ( aluminum phthalocyanine with two sulfonate groups on adjacent phthalate rings; Porphyrin Products, Logan, UT ) was added, the cells were incubated for 18 hours at 378C, washed three times with medium, and incubated for another 3 hours at 378C. The medium was removed and 200 l of AdHCMVlacZ was added. After incubation for 30 minutes at 378C, 2 mL medium was added and the cells were incubated for 30 minutes before exposure to red light ( Phillips TL 20 W/ 09, Eindhoven, The Netherlands, filtered through a Cinemoid 35 filter, with a light intensity of 13.5 W /m 2 reaching the cells ). Before analysis of the -galactosidase activity, the cells were incubated at 378C for 2 days.
X -gal staining of cells
For X -gal ( 5-bromo -4 -chloro -3 -indolyl --D -galactopyranoside) staining the medium was discarded, 1 mL of fixative solution (0.05% glutaraldehyde in PBS ) was added, and the cells were incubated at room temperature for 15 minutes. The fixative solution was discarded and the cells were washed three times in PBS at room temperature ( second rinse was for 10 minutes, first and third rinses were performed quickly). One milliliter X -gal solution ( 5 mM K 3 Fe( CN ) 6 , 5 mM K 4 Fe( CN ) 6 , 1 mM MgCl 2 , 1 mg/mL Xgal ) was added and the cells were incubated for 4 hours to overnight at 378C and observed by microscopy ( 100Â magnification ) using an Axiovert S100 microscope (Zeiss, Oberkochen, Germany ) with an MC100 Spot camera ( Zeiss ).
Flow cytometry analysis
The cells were trypsinized, centrifuged, resuspended in 25 l medium, and incubated for 5 minutes at 378C. Twenty -five microliters of 2 mM fluorescein di --D -galactopyranoside ( Molecular Probes, Eugene, OR ) was added, and the cells were incubated for 1 minute at 378C before being diluted by adding 450 l ice -cold growth medium. The samples were maintained on ice for 30 -60 minutes, filtered through a 50-m -mesh nylon filter and analyzed in a FACS -Calibur flow cytometer ( Becton Dickinson, Franklin Lakes, NJ ). For each sample 10,000 events were collected. Fluorescein fluorescence was measured through a 510 -to 530-nm filter after excitation with an argon laser ( 15 mW, 488 nm ). Dead cells were discriminated from single viable cells by gating on forward scattering versus side scattering. The data were analyzed with the CELLQuest Software (Becton Dickinson).
-Galactosidase chemiluminescent assay
To measure the production of -galactosidase protein a chemiluminescent -Gal reporter gene assay kit (Roche, Cat. No. 1 758 241, Basel, Switzerland ) was used according to the manufacturer's protocol. Briefly, the cells were washed three times with precooled PBS and 1 mL of cell lysis reagent was added to each well. After incubation for 30 minutes at room temperature the cell extract was transferred to an Eppendorf tube, centrifuged at 48C for 2 minutes at maximum speed, and 50 l of the cell extract (supernatant ) was transferred to a microtiter plate well. One hundred microliters substrate reagent was added, the microtiter plate was covered by aluminum foil and incubated at room temperature for 15 minutes to 1 hour with gentle rocking. After incubation the microtiter plate was placed in a luminometer (Victor2 Wallac 1420 Multilabel Counter, Freiburg, Germany ) and 50 l initiation solution was injected automatically. After a delay of 1 second, the light production in 5 seconds was integrated. The amount ofgalactosidase was calculated from a standard curve from samples containing known amounts of -galactosidase, and total amount of protein in the samples was measured by the Bio-Rad (Bio -Rad, Hercules, CA ) protein assay (Catalog: 500-0006 ) based on the Bradford dye -binding procedure. The amount of -galactosidase per milligram protein was calculated for each sample.
Results and discussion
In initial experiments human WiDr adenocarcinoma cells were treated with the photosensitizer AlPcS 2a , infected with the AdHCMV-lacZ adenovirus containing a -galactosidase reporter gene, and subjected to light treatment as described in Materials and methods. The cells were stained for -galactosidase activity, and microscopy showed that a substantial fraction of the photochemically treated adenovirus -infected cells expressed the transgene ( Fig 1E ) , whereas only a few positive cells were detected among nonilluminated adenovirus -infected cells (Fig 1B ) or in cells treated with virus and light but not receiving AlPcS 2a (Fig 1C ) . No positive cells were seen in untreated samples ( Fig 1A ) or in samples receiving AlPcS 2a and light, but no adenovirus ( Fig 1D ) ; thus, the observed light -induced increase in -galactosidase expression originated from the adenovirusdelivered transgene and not from an endogenousgalactosidase gene.
For quantitative analysis flow cytometry was employed, using the substrate fluorescein di --D -galactopyranoside that makes -galactosidase -expressing cells fluorescent. 17 As can be seen from Figure 2 the photochemical treatment substantially increased the -galactosidase activity in adenovirus -infected HCT 116 cells. Thus, the percentage of -galactosidase positive cells increased from 6.3 ± 0.1% ( SD, n = 3) in normally infected cells ( Ad + , S À , 0 minutes light) to 88± 17% (n = 3) in cells receiving an optimal light dose ( Ad + , S+ , 8 minutes light). Likewise for the same samples the mean fluorescence intensity increased from 52 ± 11 (n = 3) to 632 ±163 ( n= 3) relative fluorescence units ( RFU ). The photochemical treatment also slightly increased the mean fluorescence in noninfected cells (Fig 2 ) , upper and lower panels ) from 6 to 12 RFU. However, because of the very low levels of fluorescence and positive cells ( 0.4% in the Ad À , S +, 8 minutes sample ) this did not generate difficulties in interpreting the results for virus -infected cells.
In WiDr cells even higher light -dependent increases in gene transduction were observed ( Fig 3) . Thus a 22 -fold increase in the percentage of -galactosidase positive cells ( Fig 3A ) and a 44-fold increase in the mean fluorescence intensity (Fig 3B ) were found when virus -infected cells receiving an optimal light dose were compared to nonilluminated cells (Fig 3, Ad +, S + ) . In contrast, neither photochemical treatment alone ( Fig 3, Ad À , S + ) nor illumination alone ( Fig 3, Ad + , S À ) induced this increase in -galactosidase expression.
To exclude the possibility that the effects seen in the flow cytometry assay was due to a photochemically induced increase in the cellular uptake of the fluorescein di --Dgalactopyranoside substrate or to a decrease in the efflux of the fluorescent enzymatic product we performed experiments where the effect of the photochemical treatment was measured by a -galactosidase chemiluminescent enzymatic assay on cell extracts. The results ( Fig 4) corresponded well with what was obtained by flow cytometry; thus, a lightinduced increase in the amount of -galactosidase (relative to total cell protein ) of about 25-fold was obtained at optimal light doses, implying that the effects seen in the flow cytometry assay was not due to a photochemical effect on the uptake of substrate or efflux of the fluorescent enzymatic product. From Figure 4 it can also be seen that light treatment of adenovirus -infected cells not incubated with photosensitizer had no effect on the -galactosidase expression; neither had the photochemical treatment of noninfected cells.
We next studied the effect of the virus dose on the photochemically enhanced transduction efficiency. As is apparent from Figure 5 the photochemical treatment increased transduction at all virus doses tested. However, the effect was more pronounced at the lower virus doses ( MOIs 1 and 5 ) where increases in mean fluorescence of between 15-and 35-fold was observed, compared with about 10-and 5-fold increases at MOIs 20 and 50, respectively ( Fig 5B ) . It can also be seen (Fig 5A ) that the mean fluorescence obtained at the optimal light dose 
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Photochemically induced adenovirus gene delivery A Høgset et al also found for THX human melanoma and A549 human lung carcinoma cells ( data not shown ).
As previously discussed we believe that the transfection-enhancing effect of PCI on plasmid /polylysine complexes is due to a light-induced rupture of endocytic vesicles, 3, 4, 8 and it seems reasonable that the same mechanism should be involved in the stimulation of adenovirus -mediated gene transduction. However, in contrast to what is the case for plasmid /polylysine complexes, the escape of adenovirus from endosomes is believed to be an efficient process, where most of the virus particles that bind to the cell seem to reach the cell nucleus. 13, 14 How PCI can increase adenovirus-mediated gene transduction >20 times is therefore at present unclear. One possibility is that the virus particles released by the photochemical treatment may be more efficient in transduction than viruses in normal infection, e.g., due to a different release mechanism from the endosomes. It is, for example, conceivable that viral particles released by PCI might be ''more intact'' than particles released in the normal way, and that the PCI -released particles might therefore be less prone to degradation of the DNA during translocation to the nucleus. It is also possible that endosomal release of adenovirus in normal infection is less efficient at the low MOIs where PCI has the best effect. The efficiency of adenovirus gene transduction varies widely between cell lines (see, e.g., Ref. [17 ] ). This has been attributed to differences in amounts of adenovirus receptors in different cells, but relatively little is known about the relationship between the receptor content and receptor use and endosomal escape in different cell lines. Thus, at least in some cells, endosomal escape or other aspects of intracellular transport may be bottlenecks for gene transduction, as indicated for adeno -associated virus. 15 It is also possible that the photochemical treatment may affect other processes, such as virus uptake, nuclear transport or transcription of the transgene. 18 Even though PCI does not affect the uptake of plasmid /transfection agent complexes, and probably does not work by stimulating transgene transcription, 8, 9 such effects cannot presently be excluded for adenovirus vectors. Work is in progress to obtain a more detailed understanding of the photochemical effects on adenovirus gene transfer.
Although adenoviruses are among the most efficient vectors for in vivo gene delivery, their use is complicated by several serious problems, e.g., immunological reactions to the virus, transient gene expression, and bad tissue distribution leading to low transduction efficiency in target tissues. Also the ability to restrict the expression of 
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Photochemically induced adenovirus gene delivery A Høgset et al adenovirus delivered therapeutic genes to the right cells in vivo is an important issue, although progress has been made in this field employing, e.g., targeted adenoviruses, 19 tissueor disease -specific promoters, 20 or replication -restricted viruses. 21 PCI could improve several of these issues. Firstly, PCI could substantially increase the level and extent of transgene expression in target tissues. Thus, the efficiency of PCI at lower MOIs could give transduction also in areas with low virus penetration, resulting in transduction also in regions receiving too few virus particles to be effectively transduced with conventional infection. Because with local administration adenovirus concentration in tissues probably drops rapidly from the application point this may be a very important improvement of adenovirus technology. Secondly, because PCI makes it possible to obtain the same transduction efficiency with 20 times less virus than for conventional transfection, PCI could reduce problems with immunological responses to the virus. Thirdly, the photochemical treatment is highly site specific, both because only illuminated areas are affected and because photosensitizers often accumulate preferentially in diseased areas. 22 PCI could also be combined with targeted vectors, 19 potentially further improving gene delivery specificity. Thus, we have shown with plasmid /polylysine complexes targeted to the transferrin receptor that PCI works even better than with nontargeted complexes, 8 indicating that the technology is very well suited for targeted gene delivery.
The main implication of the present work is that it could pave the way for efficient site -specific in vivo gene delivery in cancer gene therapy. We have already shown that PCI with the protein toxin gelonin dramatically increases the cure rate of tumor-bearing mice, demonstrating that the PCI principle works well in vivo. 23 These studies also show that with PCI cell -killing effects are obtained in deeper layers of the tumors than can be achieved with photochemical treatment alone. Although the restricted light tissue penetration is a limitation ( exploitable penetration of about 1 cm might be expected 4, 5 ), it also makes it possible to confine gene delivery strictly to specific locations in the body. For example, by means of optical fiber devices many internal sites of disease can be effectively illuminated, 24 and the technology could also be combined with surgery, e.g., to treat residual disease after excision of tumors. As discussed above PCI should be very suitable for situations in which adenovirus is delivered by local administration; however, the technology could also make systemic administration feasible, because the photochemical treatment could increase the efficiency of gene transduction in the target areas to a therapeutic level, whereas nontarget areas, not being illuminated, would be left unaffected.
A potential drawback of the PCI technology is that it works best at cytotoxic light doses; 4 however, for tumor gene therapy, where the aim is to kill the tumor cells, this should not represent a problem. A very important point is that the cytotoxic effects are generally restricted to illuminated areas of the body; the photosensitizers in themselves usually have very little systemic toxicity. Thus, damage to vital organs could generally be avoided. In addition, there is substantial clinical experience with the use of relevant photosensitizers in cancer therapy, showing that they can be used safely in humans. 22 The photochemical treatment may also in itself induce effects (e.g., local production of immune stimulating cytokines 22 ) that could synergize with the gene therapy, potentially improving the clinical outcome. Work on in vivo applications of the technology has been initiated.
